Serveur d'exploration Tocilizumab - Curation (PubMed)

Index « Auteurs » - entrée « Yoshihito Shima »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Yoshihito Ohba < Yoshihito Shima < Yoshikazu Inoue  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000556 (2019) Yoshihito Shima [Japon]The benefits and prospects of interleukin-6 inhibitor on systemic sclerosis.
000828 (2019) Yoshihito Shima [Japon] ; Yasushi Kawaguchi [Japon] ; Masataka Kuwana [Japon]Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy.
001475 (2015) Yoshihito Shima [Japon] ; Naoki Hosen ; Toru Hirano ; Junsuke Arimitsu ; Sumiyuki Nishida ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Toshio Tanaka ; Tadamitsu Kishimoto ; Atsushi KumanogohExpansion of range of joint motion following treatment of systemic sclerosis with tocilizumab.
001529 (2013) Yoshikazu Nakaoka ; Kaori Higuchi ; Yoh Arita ; Michio Otsuki ; Kaori Yamamoto ; Takahiro Hashimoto-Kataoka ; Taku Yasui ; Kuniyasu Ikeoka ; Tomohito Ohtani ; Yasushi Sakata ; Yoshihito Shima ; Atsushi Kumanogoh ; Keiko Yamauchi-Takihara ; Toshio Tanaka ; Tadamitsu Kishimoto ; Issei KomuroTocilizumab for the treatment of patients with refractory Takayasu arteritis.
001A17 (2012) Toru Hirano [Japon] ; Nobuyuki Ohguro ; Satoshi Hohki ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Kazuyuki Yoshizaki ; Atsushi Kumanogoh ; Tadamitsu Kishimoto ; Toshio TanakaA case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
001A47 (2011) Masashi Narazaki ; Keisuke Hagihara ; Yoshihito Shima ; Atsushi Ogata ; Tadamitsu Kishimoto ; Toshio TanakaTherapeutic effect of tocilizumab on two patients with polymyositis.
001A76 (2011) Yoshihito Shima [Japon] ; Tetsuya Tomita ; Taeko Ishii ; Atsuyoshi Morishima ; Yuichi Maeda ; Atsushi Ogata ; Tadamitsu Kishimoto ; Toshio TanakaTocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis.
001A86 (2011) Sumiyuki Nishida [Japon] ; Tomio Kawasaki ; Hirokazu Kashiwagi ; Atsuyoshi Morishima ; Yoshihiro Hishitani ; Mari Kawai ; Toru Hirano ; Taeko Ishii ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Yoshihiro Oka ; Tadamitsu Kishimoto ; Toshio TanakaSuccessful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab.
001B13 (2011) Atsushi Ogata ; Atsuyoshi Morishima ; Toru Hirano ; Yoshihiro Hishitani ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Toshio TanakaImprovement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab.
001B40 (2010) Yoshihito Shima [Japon] ; Yusuke Kuwahara ; Hiroyuki Murota ; Shun Kitaba ; Mari Kawai ; Toru Hirano ; Junsuke Arimitsu ; Masashi Narazaki ; Keisuke Hagihara ; Atsushi Ogata ; Ichiro Katayama ; Ichiro Kawase ; Tadamitsu Kishimoto ; Toshio TanakaThe skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.
001C23 (2010) Toshio Tanaka ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Ichiro Kawase ; Tadamitsu KishimotoTreatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
001C25 (2009) Toshio Tanaka [Japon] ; Yusuke Kuwahara ; Yoshihito Shima ; Toru Hirano ; Mari Kawai ; Masako Ogawa ; Junsuke Arimitsu ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Ichiro Kawase ; Tadamitsu KishimotoSuccessful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
001C30 (2010) Atsushi Ogata [Japon] ; Masahide Mori ; Shoji Hashimoto ; Yukihiro Yano ; Takeya Fujikawa ; Mari Kawai ; Yusuke Kuwahara ; Toru Hirano ; Junsuke Arimitsu ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Souichirou Yokota ; Tadamitsu Kishimoto ; Ichiro Kawase ; Toshio TanakaMinimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "Yoshihito Shima" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i  \
                -Sk "Yoshihito Shima" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    Yoshihito Shima
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021